Merck Gets PTAB To Nix Johns Hopkins Cancer Drug Patent

By Theresa Schliep · June 10, 2025, 3:18 PM EDT

Merck & Co. Inc. subsidiary Merck Sharp & Dohme LLC has notched a win at the Patent Trial and Appeal Board in its disagreement with Johns Hopkins University over a cancer research...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Merck Sharp & Dohme LLC v. The Johns Hopkins University

Case Number

1:22-cv-03059

Court

Maryland

Nature of Suit

Patent

Date Filed

November 29, 2022